Variable | Death (n = 8) | Survival (n = 47) | P value |
Age (years) | 69.5 ± 10.7 | 64.5 ± 12.9 | 0.303 |
Male/case (%) | 5 (62.5) | 40 (85.1) | 0.125 |
Underlying disease |
|
|
|
Diabetes mellitus | 2 | 10 | 1.000 |
Hypertension | 4 | 22 | 0.867 |
Chronic renal insufficiency | 0 | 6 | 0.577 |
Hematologic tumor | 2 | 9 | 1.000 |
Solid Tumors | 2 | 5 | 0.580 |
Brain disease | 2 | 7 | 0.844 |
History of gout | 1 | 1 | 0.272 |
History of surgery | 4 | 19 | 0.905 |
Laboratory tests |
|
|
|
C-reactive protein (mg/L) | 171.9 ± 90.6 | 107.6 ± 95.9 | 0.086 |
Calcitoninogen (μg/L) | 39.5 ± 34.9 | 14.9 ± 28.1 | 0.032 |
Peripheral blood leukocyte count (×109/L) | 11.3 ± 9.9 | 10.9 ± 8.7 | 0.899 |
Hemoglobin (g/L) | 94.8 ± 31.6 | 108.2 ± 32.3 | 0.280 |
Albumin (g/L) | 30.2 ± 1.3 | 39.2 ± 4.3 | 0.000 |
Positive alarm time (h) | 14.9 ± 9.7 | 21.6 ± 15.3 | 0.235 |
Number of cases of recurrent bacteremia | 2 | 5 | 0.580 |
Admission to ICU | 5 | 10 | 0.047 |
Indwelling catheter | 7 | 19 | 0.029 |
Central venous catheter | 8 | 23 | 0.007 |
Mechanical ventilation | 4 | 2 | 0.001 |
Surgical procedures performed | 7 | 24 | 0.125 |
Antimicrobial exposure | 8 | 46 | 1.000 |